References:
Benzeval,
I., Bowen, C.R., Guy, R.H., Delgado-Charro, M.B., 2013. Effects of
iontophoresis, hydration, and permeation enhancers on human nail plate:
infrared and impedance spectroscopy assessment. Pharm Res 30, 1652-1662.
Bhalekar
MR, Pokharkar V, Madgulkar A, Patil N, Patil N. Preparation and Evaluation of
Miconazole Nitrate-Loaded Solid Lipid Nanoparticles for Topical Delivery. AAPS
PharmSciTech. 2009; 10: 289–296. http://dx.doi.org/10.1208/s12249-009-9199-0
Bodman
MA, Krishnamurthy K. Onychomycosis. 2022 May 1. In: StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID:28722883.
Brown,
M.B., Khengar, R.H., Turner, R.B., Forbes, B., Traynor, M.J., Evans, C.R.,
Jones, S.A., 2009. Overcoming the nail barrier: A systematic investigation of
ungual chemical penetration enhancement. Int J Pharm 370, 61-67.
Bseiso,
E.A., Nasr, M., Sammour, O.A., Abd El Gawad, N.A., 2016. Novel nail penetration
enhancer containing vesicles “nPEVs” for treatment of onychomycosis. Drug
Delivery 23, 2813-2819.
Chiu,
W.S., Belsey, N.A., Garrett, N.L., Moger, J., Price, G.J., Delgado-Charro,
M.B., Guy, R.H., 2015. Drug delivery into microneedle-porated nails from
nanoparticle reservoirs. J Control Release 220, 98-106.
Costa
PS, Mendes V, Veiga FF, Negri M, Svidzinski TIE. Relevant insights into
onychomycosis' pathogenesis related to the effectiveness topical treatment.
Microb Pathog. 2022 Jun 15;169:105640. doi: 10.1016/j.micpath.2022.105640. Epub
ahead of print. PMID: 35716926.
Dehari
D, Mehata AK, Priya V, Parbat D, Kumar D, Srivastava AK, Singh S, Agrawal AK.
Luliconazole Nail Lacquer for the Treatment of Onychomycosis: Formulation,
Characterization and In Vitro and Ex Vivo Evaluation. AAPS PharmSciTech. 2022
Jun 24;23(6):175. doi: 10.1208/s12249-022-02324-7. PMID: 35750993.
Dutet,
J., Delgado-Charro, M.B., 2009. In vivo transungual iontophoresis: Effect of DC
current application on ionic transport and on transonychial water loss. J
Control Release 140, 117-125.
Dutet,
J., Delgado-Charro, M.B., 2010. Transungual iontophoresis of lithium and
sodium: Effect of pH and co-ion competition on cationic transport numbers. J
Control Release 144, 168-174.
Fan,
X., Chen, J., Shen, Q., 2013. Docetaxel–nicotinamide complex-loaded
nanostructured lipid carriers for transdermal delivery. Int J Pharm 458,
296-304.
Haghani
I, Shams-Ghahfarokhi M, Dalimi Asl A, Shokohi T, Hedayati MT. Prevalence,
genetic diversity and antifungal susceptibility profiles of F. fujikuroi,
F. solani and Fusarium incarnatum-equiseti species complexes from
onychomycosis in north of Iran. Mycoses. 2022 Jul 1. doi: 10.1111/myc.13489.
Epub ahead of print. PMID: 35775829.
Hao,
J., Smith, K.A., Li, S.K., 2009. Iontophoretically Enhanced Ciclopirox Delivery
into and Across Human Nail Plate. J Pharm Sci 98, 3608-3616.
Jenning,
V., Gysler, A., Schäfer-Korting, M., Gohla, S.H., 2000. Vitamin A loaded solid
lipid nanoparticles for topical use: occlusive properties and drug targeting to
the upper skin. Eur J Pharm Biopharm 49, 211-218.
Mervak JE.
Hair and Nail Conditions: Nail Conditions. FP Essent. 2022 Jun;517:27-34. PMID:
35679470.
Nair,
A.B., Sammeta, S.M., Kim, H.D., Chakraborty, B., Friden, P.M., Murthy, S.N.,
2009. Alteration of the diffusional barrier property of the nail leads to greater
terbinafine drug loading and permeation. Int J Pharm 375, 22-27.
Naumann,
S., Meyer, J.P., Kiesow, A., Mrestani, Y., Wohlrab, J., Neubert, R.H., 2014.
Controlled nail delivery of a novel lipophilic antifungal agent using various
modern drug carrier systems as well as in vitro and ex vivo model systems. J
Control Release 180, 60-70
Naumann,
S., Meyer, J.P., Kiesow, A., Mrestani, Y., Wohlrab, J., Neubert, R.H., 2014.
Controlled nail delivery of a novel lipophilic antifungal agent using various
modern drug carrier systems as well as in vitro and ex vivo model systems. J
Control Release 180, 60-70.
Navarro-Bielsa
A, Gracia-Cazaña T, Robres P, Lopez C, Calvo-Priego MD, Aspiroz C, Gilaberte Y.
Combination of Photodynamic Therapy and Oral Antifungals for the Treatment of
Onychomycosis. Pharmaceuticals (Basel). 2022 Jun 7;15(6):722. doi:
10.3390/ph15060722. PMID: 35745641; PMCID: PMC9227606.
Nogueiras-Nieto,
L., Begona Delgado-Charro, M., Otero-Espinar, F.J., 2013. Thermogelling
hydrogels of cyclodextrin/poloxamer polypseudorotaxanes as aqueous-based nail
lacquers: application to the delivery of triamcinolone acetonide and ciclopirox
olamine. Eur J Pharm Biopharm 83, 370-377.
Nogueiras-Nieto,
L., Gomez-Amoza, J.L., Delgado-Charro, M.B., Otero-Espinar, F.J., 2011. Hydration
and N-acetyl-l-cysteine alter the microstructure of human nail and bovine hoof:
implications for drug delivery. J Control Release 156, 337-344.
Nogueiras-Nieto,
L., Gomez-Amoza, J.L., Delgado-Charro, M.B., Otero-Espinar, F.J., 2011.
Hydration and N-acetyl-l-cysteine alter the microstructure of human nail and
bovine hoof: implications for drug delivery. J Control Release 156, 337-344.
Obeidat,
W.M., Schwabe, K., Müller, R.H., Keck, C.M., 2010. Preservation of
nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 76, 56-67.
Olbrich
M, Ernst AL, Beltsiou F, Bieber K, Ständer S, Harder M, Anemüller W, Köhler B,
Zillikens D, Busch H, Künstner A, Ludwig RJ. Biodiversity of mycobial
communities in health and onychomycosis. Sci Rep. 2022 May 25;12(1):8872. doi:
10.1038/s41598-022-13074-8. PMID: 35614121; PMCID: PMC9133011
Ortner
VK, Nguyen N, Brewer JR, Solovyeva V, Haedersdal M, Philipsen PA. Fractional
CO<sub>2</sub> laser ablation leads to enhanced permeation of a
fluorescent dye in healthy and mycotic nails-An imaging investigation of laser-
tissue effects and their impact on ungual drug delivery. Lasers Surg Med. 2022
Aug;54(6):861-874. doi: 10.1002/lsm.23541. Epub 2022 Apr 22. PMID: 35451510.
Pardeike,
J., Hommoss, A., Müller, R.H., 2009. Lipid nanoparticles (SLN, NLC) in cosmetic
and pharmaceutical dermal products. Int J Pharm 366, 170-184.
Razavyoon
T, Hashemi SJ, Mansouri P, Rafat Z, Saboor-Yaraghi AA, Kamali Sarvestani H,
Ghasemi Z. The epidemiology and etiology of onychomycosis in 2 laboratory centers
affiliated to Tehran university of medical sciences during 2019-2020. Iran J
Microbiol. 2022 Apr;14(2):268-275. doi:10.18502/ijm. v14i2.9196. PMID:
35765553; PMCID: PMC9168250.
Sajeed
M, Wei L, Murdan S. What can GP data tell us about the treatment of
onychomycosis in the UK? Skin Health Dis. 2021 Dec 16;2(1):e84. doi:
10.1002/ski2.84. PMID: 35665209; PMCID: PMC9060066.
Shah
KA, Date AA, Joshi MD, Patravale VB. Solid lipid nanoparticles (SLN) of tretinoin:
Potential in topical delivery. Int J Pharm. 2007; 345: 163–171.
http://dx.doi.org/10.1016/j.ijpharm.2007.05.061PMid:17644288
Sharma
P, Ganta S, Denny AW, Garg S. Formulation and pharmacokinetics of lipid
nanoparticles of a chemically sensitive nitrogen mustard derivative.
Chlorambucil. Int J Pharm. 2009; 367:187–194.
http://dx.doi.org/10.1016/j.ijpharm.2008.09.032
Tanriverdi,
S.T., Ozer, O., 2013. Novel topical formulations of Terbinafine-HCl for
treatment of onychomycosis. Eur J Pharm Sci 48, 628-636.
Uemura
EVG, Barbosa MDS, Simionatto S, Al-Harrasi A, Al-Hatmi AMS, Rossato L.
Onychomycosis Caused by <i>Fusarium</i> Species. J Fungi (Basel).
2022 Mar 31;8(4):360. doi: 10.3390/jof8040360. PMID: 35448591; PMCID:
PMC9027400.
van
Hoogdalem, E.J., van den Hoven, W.E., Terpstra, I.J., van Zijtveld, J.,
Verschoor, J.S.C., Visser, J.N., 1997. Nail penetration of the antifungal agent
oxiconazole after repeated topical application in healthy volunteers, and the
effect of acetylcysteine. Eur J Pharm Sci 5, 119- 127
Vejnovic,
I., Simmler, L., Betz, G., 2010. Investigation of different formulations for
drug delivery through the nail plate. Int J Pharm 386, 185-194.
Wessel,
S., Gniadecka, M., Jemec, G.B.E., Wulf, H.C., 1999. Hydration of human nails
investigated by NIR-FT-Raman spectroscopy. Biochim Biophys Acta 1433, 210-216.
Yoon,
G., Park, J.W., Yoon, I.-S., 2013. Solid lipid nanoparticles (SLNs) and
nanostructured lipid carriers (NLCs): recent advances in drug delivery. J Pharm
Invest 43, 353-362.